Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.21%
1,087.30
-13.27
-1.21%
—1,100.571,098.941,103.801,085.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.02%
605.04
-0.11
-0.02%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.26%
1,210.19
+15.00
+1.26%
—1,195.191,204.711,217.721,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.46%
1,714.55
-25.36
-1.46%
—1,739.911,734.501,734.501,713.35——
SIXM
Financials
SIXM
Financials
SIXM
+0.43%
641.33
+2.77
+0.43%
—638.56640.21645.32639.66——
SIXR
Staples
SIXR
Staples
SIXR
+0.76%
837.86
+6.29
+0.76%
—831.57840.48843.98834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.29%
213.97
+0.61
+0.29%
—213.36213.36215.54212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.78%
3,176.70
-57.48
-1.78%
—3,234.183,171.863,195.363,156.24——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.03%
935.95
+0.30
+0.03%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,453.68
+4.42
+0.30%
—1,449.261,454.771,462.651,452.87——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.56%
2,369.06
-13.39
-0.56%
—2,382.452,371.192,380.452,367.31——
KROS:NASDAQ
Keros Therapeutics Inc
$11.36
+3.18%
(+0.35) 1D
Apr 28, 10:44:49 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
$11.04
High
$11.44
Low
$11.04
Mkt. cap
225.78M
Avg. vol.
485.96K
Volume
43.57K
P/E ratio
4.96
52-wk high
$22.55
52-wk low
$10.42
EPS
$2.30
Beta
0.98
Shares outstanding
19.72M
No. of employees
78
News stories
From sources across the web
About Keros Therapeutics Inc
CEO-
Employees78
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitekerostx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
211.25M
18.17M
14.26M
385.00K
Cost of goods sold
48.71M
43.50M
19.52M
17.81M
Cost of revenue
48.71M
43.50M
19.52M
17.81M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.50M
14.48M
10.13M
11.74M
Operating expense
10.50M
14.48M
10.13M
11.74M
Total operating expenses
59.21M
57.98M
29.65M
29.56M
Operating income
152.04M
-39.82M
-15.38M
-29.17M
Other non operating income
-
-
-
-539.00K
EBT including unusual items
158.49M
-32.92M
-8.70M
-24.98M
EBT excluding unusual items
158.49M
-32.92M
-8.70M
-24.88M
Income tax expense
10.04M
-2.22M
-1.42M
-1.51M
Effective tax rate
6.34%
6.75%
16.36%
6.06%
Other operating expenses
-
-
-
-
Net income
148.45M
-30.70M
-7.28M
-23.46M
Net profit margin
70.27%
-168.96%
-51.04%
-6,093.77%
Earnings per share
3.62
-0.76
-0.18
-0.86
Interest and investment income
6.79M
7.12M
6.93M
4.02M
Interest expense
-
-
-
-
Net interest expenses
6.79M
7.12M
6.93M
4.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
152.38M
-39.45M
-14.99M
-28.77M
Gain or loss from assets sale
-
-14.00K
-
1.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer